1. They are not an institution, they are a RIA. 2. A PR says discussions with three agencies does not mean they are discussing cd-12 or they are even considering it. An email to the agencies could be considered "discussions". No information in a PR is a negative. No data for a clinical stage company is a negative. 3. Where is the S-3 for Fife. A few people on twitter were discussing this and I have to agree it is odd. Could CYDY be in default which would cause another suit from Fife in which CYDY had to give them $22m for the $5m loan?
Just because they issued a PR about discussions doesn't mean anything of value is coming. They can be discussing anything. Most likely CYDY did not meet endpoints and in the best case NP is trying to sell some minor subset data.
Remember CYDY trial on CD10 failed as well and company was trying to use subset data regarding NEWS to sell itself. FDA wanted nothing to do with LL.
Glad you made some money in the covid frenzy. Most biotech investors did early on. Dust is settling now with vaccines.
Also CYDY investors advanced on HIV speculation but what has happened recently. Nothing. FDA rejected the BLA. The company again has hidden why the BLA was rejected and what needed to be done to fix it. You do realize that other companies have been working on HIV and their drugs will be coming to market long before CYDY solves its issues, if it ever does.
As to institutional investors every company has them. But CYDY has a far greater proportion of retail investors, mostly because of its ability to drag in naive investors.
News 
Market Data 
Discover 
